Literature DB >> 9034195

Acute in vitro production of acylation stimulating protein in differentiated human adipocytes.

M Maslowska1, T Scantlebury, R Germinario, K Cianflone.   

Abstract

We have previously shown that in normolipidemic healthy adults, plasma acylation stimulating protein (ASP) increases postprandially and is produced in vitro by cultured differentiated human adipocytes. The present studies were undertaken to examine the influence of specific plasma components on endogenous ASP production in cultured human adipocytes. The results demonstrate that neither glucose nor fatty acids (over a wide range of concentrations) had any substantial effect on ASP production. Insulin increased ASP production up to 2-fold (208% +/- 18%, P < 0.01). However, the most profound increase in ASP was generated by the addition of chylomicrons to the cell culture medium. Chylomicrons (CHYLO) obtained from postprandial plasma increased ASP production in a time- and concentration-dependent manner, producing up to a 150-fold increase in ASP at the highest concentration of CHYLO tested (500 microg triacylglycerol/mL medium (P < 0.001)). By contrast, very low (VLDL), high (HDL), and low density lipoproteins (LDI) had only marginal effects. The effects on ASP parallelled the changes in adipocyte C3 secretion (the precursor protein of ASP). As with ASP, glucose, oleate, insulin, and hepatic lipoproteins (VLDL, LDL, and HDL) had little or no effect on C3 secretion. In contrast, CHYLO had an even greater effect on C3 secretion than on ASP generation. Finally, the effects of CHYLO on generation of ASP and C3 were not dependent on lipolysis of CHYLO by lipoprotein lipase (LPL). These results are consistent with the changes in plasma ASP seen postprandially, and suggests a role of ASP as a positive feedback regulator of triacylglycerol synthesis in adipose tissue.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9034195

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  12 in total

1.  Ethnic differences in acylation stimulating protein (ASP) in Xinjiang Uygur autonomous region, China.

Authors:  Ying Gao; Xiang Xie; Katherine Cianflone; Marc Lapointe; Jie Guan; Gao Wa Bai Bu-Jiaer; Dan Chen; Wei-Yun Zhao; Yi-Tong Ma
Journal:  Int J Clin Exp Med       Date:  2015-02-15

2.  Socioecological predictors of immune defences in wild spotted hyenas.

Authors:  Andrew S Flies; Linda S Mansfield; Emily J Flies; Chris K Grant; Kay E Holekamp
Journal:  Funct Ecol       Date:  2016-02-29       Impact factor: 5.608

3.  Lipoprotein lipase deficiency is associated with elevated acylation stimulating protein plasma levels.

Authors:  Sabina Paglialunga; Pierre Julien; Youssef Tahiri; Francois Cadelis; Jean Bergeron; Daniel Gaudet; Katherine Cianflone
Journal:  J Lipid Res       Date:  2009-02-23       Impact factor: 5.922

Review 4.  The role of the complement system in metabolic organs and metabolic diseases.

Authors:  Julia Phieler; Ruben Garcia-Martin; John D Lambris; Triantafyllos Chavakis
Journal:  Semin Immunol       Date:  2013-05-17       Impact factor: 11.130

Review 5.  Metabolic liver disease of obesity and role of adipose tissue in the pathogenesis of nonalcoholic fatty liver disease.

Authors:  Kamran Qureshi; Gary A Abrams
Journal:  World J Gastroenterol       Date:  2007-07-14       Impact factor: 5.742

6.  CD55 deficiency protects against atherosclerosis in ApoE-deficient mice via C3a modulation of lipid metabolism.

Authors:  Ruth D Lewis; Mark J Perry; Irina A Guschina; Christopher L Jackson; B Paul Morgan; Timothy R Hughes
Journal:  Am J Pathol       Date:  2011-08-02       Impact factor: 4.307

7.  Association of adipocyte genes with ASP expression: a microarray analysis of subcutaneous and omental adipose tissue in morbidly obese subjects.

Authors:  Robin E MacLaren; Wei Cui; HuiLing Lu; Serge Simard; Katherine Cianflone
Journal:  BMC Med Genomics       Date:  2010-01-27       Impact factor: 3.063

8.  Acylation stimulating protein reduction precedes insulin sensitization after BPD-DS bariatric surgery in severely obese women.

Authors:  M N Munkonda; J Martin; P Poirier; A Carrington; S Biron; S Lebel; K Cianflone
Journal:  Nutr Diabetes       Date:  2012-08-20       Impact factor: 5.097

9.  Rosiglitazone decreases postprandial production of acylation stimulating protein in type 2 diabetics.

Authors:  Youssef Tahiri; Fredrik Karpe; Garry D Tan; Katherine Cianflone
Journal:  Nutr Metab (Lond)       Date:  2007-05-09       Impact factor: 4.169

Review 10.  Dyslipidemia in obesity: mechanisms and potential targets.

Authors:  Boudewijn Klop; Jan Willem F Elte; Manuel Castro Cabezas
Journal:  Nutrients       Date:  2013-04-12       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.